“Toward a system plan for transforming cancer care to a molecular-based approach”: Recommendations from an expert panel

• Rick Wilson, Director, The Genome Institute at Washington Univ. School of Medicine • Judy Garber, Director, Cancer Risk/Prevention Clinic, Dana Farber • Shashikant Kulkarni, Head of Clinical Genomics, Wash. University School of Medicine • Shyamali Singhal, Medical Director of the Cancer Center, El Camino Hospital • Nickolas Papadopoulos, Director of Translational Genetics, Johns Hopkins Medicine • John Sweetenham, CMO, Huntsman Cancer Institute • Paula Rieger, CEO, Oncology Nurses Society • Nazneen Aziz, Director of Molecular Medicine, College of American Pathologists • Mary Zutter, Director, Tumor-Host Interaction Program, Vanderbilt Ingram Cancer Center • Tim McDaniel, Director of Scientific Research, Illumina Inc. • Les Paul, CMO, Caris Life Science • Dawn Van Dam, CEO, Health Connexions • Anthony Flynn, Associate, AcceleratorH